The US Food and Drug Administration and the medtech industry will miss a 15 January congressional deadline to send a user-fee deal to Congress for approval. Insiders with knowledge of the negotiations disagree, however, on how far apart the two sides are on reaching a deal.
Industry groups including AdvaMed, the Medical Device Manufacturers Association (MDMA) and the Medical Imaging and Technology Alliance (MITA) have yet...